<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01321424</url>
  </required_header>
  <id_info>
    <org_study_id>ALRGN01</org_study_id>
    <nct_id>NCT01321424</nct_id>
  </id_info>
  <brief_title>Diurnal Variation in Tear Osmolarity</brief_title>
  <official_title>Investigator Sponsored, Pilot Study to Assess the Diurnal Variation in Tear Osmolarity as a Predictor of Dry Eye Disease Etiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ophthalmic Consultants of Long Island</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ophthalmic Consultants of Long Island</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the change in Tear Osmolarity during the course of&#xD;
      the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and&#xD;
      differentiate between the two forms of dry eye.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The premise of this study is that dry eye disease, specifically tear osmolarity, changes&#xD;
      during the course of the day based on the etiology of the dry eye and that aqueous-deficiency&#xD;
      dry eye will worsen during the course of the day while meibomian gland deficiency will&#xD;
      stabilize or possibly even improve during the course of the day.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The measured difference in Tear Osmolarity during the course of the day to support clinical diagnosis and differentiate between aqueous-deficiency and meibomian gland disease.</measure>
    <time_frame>1 Day (AM and PM Diurnal)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular Improvement</measure>
    <time_frame>31 Days</time_frame>
    <description>Improvement in Ocular Surface Disease Index, Best Corrected Visual Acuity, Uncorrected Visual Acuity, Slit Lamp Exam, Schirmer test, Lissamine green conjunctival staining, Fluorescein corneal staining and Tear Break Up Time</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Dry Eye Disease</condition>
  <arm_group>
    <arm_group_label>Aqueous Dificiency Dry Eye</arm_group_label>
    <description>20 Participants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meibomian Gland Disease Dry Eye</arm_group_label>
    <description>20 Participants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Eye</arm_group_label>
    <description>20 Participants</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care facility&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy males and females ≥ 18 years old&#xD;
&#xD;
          2. Negative urine pregnancy results for females of childbearing potential&#xD;
&#xD;
          3. Able to read and sign an informed consent form and show willingness to comply with the&#xD;
             study protocol visits and procedures&#xD;
&#xD;
          4. Has 20/40 BCVA or better in at least one eye&#xD;
&#xD;
          5. Does not currently wear contact lenses&#xD;
&#xD;
          6. For Aqueous-Deficiency Group:&#xD;
&#xD;
               -  Has symptoms of Dry Eye&#xD;
&#xD;
               -  Schirmer testing ≤ 10 mm&#xD;
&#xD;
               -  Tear Break Up Time ≤ 8 seconds&#xD;
&#xD;
               -  Conjunctival staining ≥ 1+&#xD;
&#xD;
               -  Meibomian gland inspissations ≤ 1+&#xD;
&#xD;
               -  No lid thickening, lid erythema, or thickened, turbid meibomian gland secretions&#xD;
&#xD;
          7. For Meibomian Gland Disease Group:&#xD;
&#xD;
               -  Has symptoms of Dry Eye&#xD;
&#xD;
               -  Schirmer testing ≥ 10 mm&#xD;
&#xD;
               -  Tear Break Up Time ≤ 8 seconds&#xD;
&#xD;
               -  Conjunctival staining ≥ 1+&#xD;
&#xD;
               -  Meibomian gland inspissations ≥ 2+&#xD;
&#xD;
          8. For Normal Group:&#xD;
&#xD;
               -  Has no symptoms of Dry Eye&#xD;
&#xD;
               -  Schirmer testing &gt; 10 mm&#xD;
&#xD;
               -  Tear Break Up Time &gt; 8 seconds&#xD;
&#xD;
               -  No or trace Conjunctival staining&#xD;
&#xD;
               -  No Meibomian gland inspissations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any topical medication within the last three months, except for artificial tears&#xD;
&#xD;
          2. Unable to discontinue use of artificial tears during the course of the day for Visit 2&#xD;
&#xD;
          3. Any Systemic disease, which in the opinion of the Investigator, may affect ocular&#xD;
             health or confound study results&#xD;
&#xD;
          4. Any active ocular disease other than Dry Eye Disease, Meibomian Gland Disease or&#xD;
             Sjogren's Syndrome, which in the opinion of the Investigator, may affect ocular health&#xD;
             or confound study results&#xD;
&#xD;
          5. Clinically significant lid or conjunctival abnormalities, neovascularization, corneal&#xD;
             scars or corneal opacities&#xD;
&#xD;
          6. Clinically significant limbal or bulbar injection, or corneal staining not due to DES&#xD;
&#xD;
          7. Has worn hard or rigid gas permeable contact lenses within 1 year&#xD;
&#xD;
          8. Has worn soft contact lenses within 1 week&#xD;
&#xD;
          9. Has had eye surgery or an eye injury within 6 months&#xD;
&#xD;
         10. Positive urine pregnancy results for females of childbearing potential&#xD;
&#xD;
         11. Any changes in current medication within 30 days of Visit 2 or anticipated change&#xD;
             during course of study, which in the opinion of the Investigator may confound study&#xD;
             results&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric D Donnenfeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophthalmic Consultants of Long Island</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara Burger, RN</last_name>
    <role>Study Director</role>
    <affiliation>Ophthalmic Consultants of Long Island</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Connecticut</name>
      <address>
        <city>Fairfield</city>
        <state>Connecticut</state>
        <zip>06824</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Long Island</name>
      <address>
        <city>Lynbrook</city>
        <state>New York</state>
        <zip>11563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Long Island</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Long Island</name>
      <address>
        <city>Port Jefferson</city>
        <state>New York</state>
        <zip>11777</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Long Island</name>
      <address>
        <city>Rockville Centre</city>
        <state>New York</state>
        <zip>11570</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Long Island</name>
      <address>
        <city>Valley Stream</city>
        <state>New York</state>
        <zip>11581</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>March 21, 2011</study_first_submitted>
  <study_first_submitted_qc>March 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2011</study_first_posted>
  <last_update_submitted>April 22, 2016</last_update_submitted>
  <last_update_submitted_qc>April 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dry Eye</keyword>
  <keyword>Tear Osmolarity</keyword>
  <keyword>Meibomain Gland Disease</keyword>
  <keyword>Aqueous Dificiency</keyword>
  <keyword>Tear film abnormality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>PI will present study outcomes to associates</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

